|
||||||||||||||||||||||||||||||||||
SurgeonRecently enterosgel are increasingly used in various fields of surgery. This is, above all, with the capacity of local and systemic detoxification, which can be solved only with the use of sorbents. Enterosgel able to tackle a wider range of tasks associated with bacterial infections, disorders of metabolism and digestive function, which often accompany and complicate the disease during surgery. The high sorption activity and specificity enterosgelya, as well as its physical and chemical properties allow it to use in various fields of surgery. An important factor is the simplicity and low cost of the sorption of therapy, which makes it accessible to everyday praktiki.Enterosgel application can be applied to the unaffected skin, as well as directly on the wound surface in cases of traumatic tissue loss (as in private or public harm), with burn trauma, purulent-inflammatory processes. Enterosgel may be imposed and on the surface of mucous membranes: the urogenital system, the various divisions of the gastrointestinal tract. Enterosgel can be used in the composition of solutions used for washing wound tissue injury, lavage. Shown that the therapeutic effect of dialysis pareticheski modified intestine increases significantly if his conduct enterosgel use. in surgical gastroenterology Enterosgel use:
Enterosgel reduces excessive microbial contamination small bowel in patients with frequent peritonitis, Application of the enterosorbent in patients with peritonitis at 2 days reduces the nearly 2-fold titer bacterial seed separated from nazointestinalnyh probes, and by the 4 th days treatment - in 3,8 times. Significantly reduced the number of microbial associations in 25% of patients on the 3rd day of growth of aerobic microflora in the intestinal detachable no. At the same time, without the use of Enterosgelya within 3 days of treatment the level of microbial seed separated from nazointestinalnyh probes remained consistently high, 2-fold increased percentage of sowing microbial associations. Also, when applying Enterosgelya throughout the 4-day treatment comes clear reduction of VSMM in intestinal contents: 2 nd day the number of decreases in 2.5 times, and to the 4 th days of reaching normal values. In patients not taking Enterosgel for the first 4 days after the operation toxicity intestinal contents remained consistently high.
The increase reflects the recovery of sIgA intestinal barrier, as is well known that sIgA as a result of transtsitoza is produced on the surface of mucosa through the epithelial layer. Reduced content of autoantibodies due to reduced levels of LPS stimulation of B-lymphocytes (decrease polyclonal activation). Characteristically, in the absence of enterosorption levels of autoantibodies to small bowel decreased only two times.
|
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||